BioRestorative Therapies (BRTX) Revenue (2012 - 2025)
BioRestorative Therapies' Revenue was $19,600 in Q4 2025, down 54.7% from $43,300 a year earlier but up 66.1% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Revenue (2012 - 2025) Analysis & Trends
For FY2025, Revenue at BioRestorative Therapies came in at $359,700, down 10.3% from FY2024.
- Revenue shows a five-year compound annual growth rate of 36.1% (FY2020 to FY2025).
- In earlier years, Revenue was $401,000 in FY2024 (+175.0%), $145,800 in FY2023 (+21.7%), $119,800 in FY2022 (+160.4%) and $46,000 in FY2021 (-40.3%).
- Quarterly Revenue has moved between $3,700 (Q4 2022) and $303,300 (Q2 2025) over five years.
- Compared with a year earlier, Revenue was higher in five of the last eight quarters, with growth averaging 112.2%.
- The best year-over-year quarter for Revenue over five years was Q3 2024 (growth of 660.9%); the worst was Q3 2025 (a decline of 94.9%).
- Per Business Quant data, BRTX's Revenue in the three quarters before Q4 2025 was $11,800 (Q3 2025), $303,300 (Q2 2025) and $25,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | BioRestorative Therapies | 687,973.67 | -23.25 Mn | 17,964.00 | 19,600.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 19,600.00 |
| Sep 30, 2025 | 11,800.00 |
| Jun 30, 2025 | 303,300.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 43,300.00 |
| Sep 30, 2024 | 233,600.00 |
| Jun 30, 2024 | 89,100.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 19,300.00 |
| Sep 30, 2023 | 30,700.00 |
| Jun 30, 2023 | 64,500.00 |
| Mar 31, 2023 | 31,300.00 |
| Dec 31, 2022 | 3,700.00 |
| Sep 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 71,100.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 18,000.00 |
API Access
BioRestorative Therapies Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();